IV Magnesium in the Treatment of Acute Dysmenorrhea

Recruiting now · Not applicable

Conditions studied: Dysmenorrhea

In brief

This prospective, randomized, double-blind clinical trial aims to evaluate the analgesic efficacy of intravenous magnesium sulfate in women presenting to the emergency department with acute dysmenorrhea. Participants will be randomized into two groups receiving either 2 ampoules of magnesium sulfate or intravenous dexketoprofen. Pain levels will be assessed using the Visual Analog Scale (VAS) before and after treatment.

Key facts

Study ID

NCT07248540

Run by

Havva Betül Bacak

People needed

60

Starts

2025-07-01

Expected to finish

2026-01-01

Last updated by the study team

2025-11-25

Who can join

Age: 18 and older, up to 35. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Female patients aged 18 to 35 years
• Presenting to the obstetrics and gynecology emergency department with a diagnosis of primary dysmenorrhea
• Having regular menstrual cycles within the last 6 months
• Having a Visual Analog Scale (VAS) pain score of ≥6 at emergency admission
• Providing written informed consent for participation in the study

You may not qualify if…

• Patients with secondary dysmenorrhea or underlying gynecological pathology
• Pregnancy or breastfeeding
• Use of analgesics or muscle relaxants within the last 3 days
• Known allergy to magnesium sulfate or dexketoprofen trometamol
• History of renal failure, cardiac arrhythmia, or serious systemic disease
• Inability to assess pain due to mental disability or communication disorder
• Failure to provide informed consent for participation in the study

Where it is running

• SBÜ Gaziosmanpaşa Training and Research Hospital — Gaziosmanpaşa, Outside of the US, Turkey (Türkiye) (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.